MedTrace Logo

Safety and Effectiveness of STYLAGE® L for Correction of Moderate and Severe Nasolabial Folds in Chinese Adults

NCT04861766 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 390

Last updated 2023-04-19

No results posted yet for this study

Summary

This is a safety and efficacy study of STYLAGE® Lin Chinese adults with Nasolabial Folds.

Conditions

  • Aging
  • Skin Wrinkling

Interventions

DEVICE

STYLAGE® L

Injection in both NLFs

DEVICE

Active Comparator

Injection in both NLFs

Sponsors & Collaborators

  • Laboratoires Vivacy

    lead INDUSTRY

Principal Investigators

  • Yan Wu · Peking University First Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-06
Primary Completion
2022-08-16
Completion
2023-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04861766 on ClinicalTrials.gov